Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

As for the AI bubble, it is coming up for conversation because it is now having a material effect on the economy at large.

Most recent closings and delays are listed here when there are active closures. Enter your email and we’ll send a secure one-click link to sign in. Please enter a valid email address By clicking on ...